VIM- and IMP-Type Metallo-β-lactamase–Producing Pseudomonas spp. and Acinetobacter spp. in Korean Hospitals
2003

Metallo-β-lactamase Producing Bacteria in Korean Hospitals

Sample size: 654 publication Evidence: moderate

Author Information

Author(s): Lee Kyungwon, Lee Wee Gyo, Uh Young, Ha Gyoung Yim, Cho Jihyun, Chong Yunsop

Primary Institution: Yonsei University College of Medicine

Hypothesis

What is the occurrence of acquired metallo-β-lactamase (MBL)–producing bacteria in Korean hospitals?

Conclusion

More than 10% of imipenem-nonsusceptible isolates of Pseudomonas spp. and Acinetobacter spp. were found to be MBL producers, indicating a significant prevalence in Korean hospitals.

Supporting Evidence

  • 44 out of 387 Pseudomonas spp. and 38 out of 267 Acinetobacter spp. infections produced MBL.
  • MBL-producing isolates were detected in 60.7% of the hospitals surveyed.
  • VIM-2 was the only type of acquired MBL identified initially in Korea.

Takeaway

In Korean hospitals, some bacteria that are resistant to a strong antibiotic called imipenem are making a special enzyme that makes them even harder to treat.

Methodology

Isolates were collected from 28 hospitals, and MBL production was screened using specific tests, including PCR for gene detection.

Limitations

The study may not represent all hospitals in Korea as it only included 28 hospitals and relied on the collection of imipenem-nonsusceptible isolates.

Participant Demographics

Isolates were mainly from inpatients and intensive-care unit patients.

Digital Object Identifier (DOI)

10.3201/eid0907.030012

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication